4DMedical Limited (ASX:4DX) Secures Contract with University of Chicago Medicine
Contract with University of Chicago Medicine
4DMedical Limited (ASX: 4DX) announces a significant commercial contract with the University of Chicago Medicine. This partnership allows clinicians at UChicago Medicine to use 4DMedical’s innovative lung imaging products, including the CT LVAS™ technology.
Enhancing Patient Care
The contract aligns with UChicago Medicine’s focus on advancing complex lung disease treatments. Dr. Kyle Hogarth, a leading pulmonologist at UChicago Medicine, expressed enthusiasm for the partnership, stating, “With the addition of CT LVAS™ and other products, we believe we have taken the next step in maximizing the information that can be obtained from a chest CT.”
Expansion of UCSD Health Contract
In addition to the UChicago Medicine agreement, 4DMedical also announced the expansion of its contract with the University of California San Diego (UCSD) Health. The expanded agreement now includes the SeleCT screening service, which identifies eligible patients for endobronchial valve treatment.
CEO Comments on Growth
4DMedical’s Managing Director and CEO, Andreas Fouras, highlighted the contract as a pivotal development in their U.S. expansion strategy. He remarked, “This contract, in combination with the immediate growth in contract value from UCSD Health, clearly demonstrates the demand for our comprehensive portfolio of products.”
Motley Fool contributor Lauren Surplice has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
This article was generated using GPT-4o mini, a Large Language Model (LLM), to generate summaries of investing news. While AI is generating the content, we know better than to blindly trust our future robot overlords, and every article is edited and fact-checked by an editor holding the appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content of everything published by The Capital Club.